The importance of methods for site performance evaluation in REPRIEVE, a longitudinal, global, multicenter trial-Reference-Cited by-同舟云学术

The importance of methods for site performance evaluation in REPRIEVE, a longitudinal, global, multicenter trial

Published:2023-01 Issue: Volume:124 Page:107035
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Fulda Evelynne S.,Fichtenbaum Carl J.,Kileel Emma M.,Zanni Markella V.,Aberg Judith A.,Malvestutto Carlos,Cardoso Sandra Wagner,Berzins Baiba,Lira Rita,Harden Regina,Robbins Gregory,Martinez Maria,Nieves Sylvia Davila,McCallum Sara,Cruz Jorge Leon,Umbleja Triin,Sprenger Heather,Giguel Francoise,Bone Frederic,Wood Ken,Byroads Mark,Paradis Kayla,Lu Michael T.,Douglas Pamela S.,Ribaudo Heather J.,Grinspoon Steven K.,Fitch Kathleen V.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference6 articles.

1. Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE);Grinspoon;Am. Heart J.,2019

2. Successful recruitment of a multi-site international randomized placebo-controlled trial in people with HIV with attention to diversity of race and ethnicity: critical role of central coordination;Fitch;HIV Research & Clinical Practice,2020

3. Assessing site performance in the Altair study, a multinational clinical trial;Berthon-Jones;Trials,2015

4. On behalf of the Site Performance Metrics for Multicentre Randomised Trials, Development of a standardised set of metrics for monitoring site performance in multicentre randomised trials: a Delphi study;Whitham;Trials,2018

5. Monitoring performance of sites within multicentre randomised trials: a systematic review of performance metrics;Walker;Trials,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Operational complexities in international clinical trials: a systematic review of challenges and proposed solutions;BMJ Open;2024-04

2. Comparing implications of cardiovascular risk of abacavir and integrase inhibitors: why scientific community is confused and timid?;AIDS;2023-05-01